Skip to content

Determining Depression Treatment Preferences of Low-Income Latinos in Primary Care Settings

Patient-Centered Depression Care in the Public Sector

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00260169
Enrollment
432
Registered
2005-12-01
Start date
2005-11-30
Completion date
2009-01-31
Last updated
2013-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Keywords

Treatment Preferences, Public sector, Latino

Brief summary

This study will determine ways to make depression care more responsive to the needs of consumers in primary care clinics serving low-income Latinos.

Detailed description

Depression is a serious illness that is difficult to diagnose and treat, especially in populations that underutilize mental health services. The Latino population is one such group. Accommodating patient preferences for care, provider capacities, and administrator priorities is essential to the development of effective depression care interventions that are sustainable in public sector systems. However, little is understood regarding the depression treatment preferences of low-income Latinos who have not received quality depression care and who may not feel that they can voice their opinions about their health care. In addition, little is known about the preferences, capabilities, and priorities of providers and administrators in primary care clinics. This study will determine ways to make depression care more responsive to the needs of consumers in primary care clinics serving low-income Latinos. The study will also evaluate the effectiveness of various treatments in reducing depression. Following baseline assessments of depression treatment preferences and resources, participants in this open label study will be randomly assigned to receive collaborative care either immediately or after a waiting period. Individuals assigned to receive immediate care will undergo treatment for 12 weeks. Other participants will receive treatment at a later time. All participants will have the option to receive one of the following treatments: (1) medication management from the Depression Care Specialist (DCS) and antidepressant medication from their primary care provider (PCP); (2) cognitive-behavioral therapy from the DCS; or (3) a combination of both treatments. Depression treatment outcomes and preferences will be measured post-intervention. Provider and administrator preferences will also be measured post-intervention and potential strategies for implementing patient-centered depression care programs will be identified.

Interventions

Patients receiving collaborative care treatment choose 12 weeks of CBT and/or medication management (antidepressants prescribed by patients' primary care provider) from the study depression care specialist (DCS).

BEHAVIORALEnhanced usual care

Usual care participants are assigned to a 16-week wait-list for the study treatment, during which they are free to receive treatment elsewhere. A letter is given to participants' primary care providers (PCP) that indicates they screened positive for depression. In addition, patients receive an information booklet about depression and a community resource list.

Sponsors

National Institute of Mental Health (NIMH)
CollaboratorNIH
University of Southern California
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

For Participating Patients: * Attending one of the study clinics for primary care * English or Spanish-speaking * Screens positive for major depressive disorder or dysthymia For Providers: * All primary care providers providing at least one day of services at one of the study clinics For Administrators: * Administrative, medical, and nursing directors from each study site and directors of affiliated local mental health clinics

Exclusion criteria

For Participating Patients: * Acutely suicidal * Screens positive for bipolar disorder, psychotic disorder, or cognitive impairment

Design outcomes

Primary

MeasureTime frame
Depression treatment preferences as measured by a conjoint analysis survey and qualitative interviewsMeasured at Week 16

Secondary

MeasureTime frame
Depression outcomes as measured by the Patient Health Questionnaire-9Measured at Week 16

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026